These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2031709)

  • 1. Some central pharmacological effects of the calcium channel antagonist flunarizine.
    Czyrak A; Mogilnicka E; Maj J
    J Neural Transm Gen Sect; 1991; 83(3):179-88. PubMed ID: 2031709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological involvement of the calcium channel blocker flunarizine in dopamine transmission at the striatum.
    Belforte JE; Magariños-Azcone C; Armando I; Buño W; Pazo JH
    Parkinsonism Relat Disord; 2001 Sep; 8(1):33-40. PubMed ID: 11472878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
    Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
    Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviour.
    Carter CJ; Pycock CJ
    Life Sci; 1978 Sep; 23(9):953-60. PubMed ID: 568208
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of flunarizine on dopamine dependent behaviours in rats.
    Moorthy NS; Balsara JJ
    Indian J Med Sci; 1999 Feb; 53(2):43-8. PubMed ID: 10798022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.
    Yamawaki S; Lai H; Horita A
    J Pharmacol Exp Ther; 1983 Nov; 227(2):383-8. PubMed ID: 6631720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic modulation of footshock induced aggression in paired rats.
    Datla KP; Mitra SK; Bhattacharya SK
    Indian J Exp Biol; 1991 Jul; 29(7):631-5. PubMed ID: 1839019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dihydropyridine compounds in behavioural tests of dopaminergic activity.
    Bourson A; Gower AJ; Mir AK; Moser PC
    Br J Pharmacol; 1989 Dec; 98(4):1312-8. PubMed ID: 2482105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
    Arnt J; Bøgesø KP; Hyttel J; Meier E
    Pharmacol Toxicol; 1988 Mar; 62(3):121-30. PubMed ID: 3259694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of 5-hydroxytryptaminergic antagonists upon apomorphine- and lergotrile-induced hypothermia and stereotyped behaviour in rats.
    Wade RL; Quock RM; Malone MH
    J Pharm Pharmacol; 1984 Oct; 36(10):673-6. PubMed ID: 6150084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apomorphine-induced penile erection and yawning: site of action in brain.
    Melis MR; Argiolas A; Gessa GL
    Brain Res; 1987 Jul; 415(1):98-104. PubMed ID: 3497688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of putative dopamine D3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats.
    Kurashima M; Yamada K; Nagashima M; Shirakawa K; Furukawa T
    Pharmacol Biochem Behav; 1995 Nov; 52(3):503-8. PubMed ID: 8545466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior.
    Weiner WJ; Carvey PM; Nausieda PA; Klawans HL
    Neurology; 1979 Dec; 29(12):1622-5. PubMed ID: 41197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roxindole, a dopamine autoreceptor agonist with a potential antidepressant activity. II. Effects on the 5-hydroxytryptamine system.
    Maj J; Kołodziejczyk K; Rogóz Z; Skuza G
    Pharmacopsychiatry; 1997 Mar; 30(2):55-61. PubMed ID: 9131725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets.
    Löschmann PA; Smith LA; Lange KW; Jaehnig P; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1991; 105(3):303-9. PubMed ID: 1686813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between yawning behavior and central serotonergic neuronal system in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):667-72. PubMed ID: 2957600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study.
    Tang AH; Himes CS
    Eur J Pharmacol; 1995 Sep; 284(1-2):13-8. PubMed ID: 8549616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apomorphine hypothermia: interaction with serotonergic agents.
    Kulkarni SK
    Pol J Pharmacol Pharm; 1980; 32(1):15-20. PubMed ID: 7192860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.